STOCK TITAN

COMPASS Pathways Plc American Depository Shares - $CMPS STOCK NEWS

Welcome to our dedicated page for COMPASS Pathways Plc American Depository Shares news (Ticker: $CMPS), a resource for investors and traders seeking the latest updates and insights on COMPASS Pathways Plc American Depository Shares stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect COMPASS Pathways Plc American Depository Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of COMPASS Pathways Plc American Depository Shares's position in the market.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.85%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.9%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.66%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.85%
Tags
management
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.37%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.36%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.74%
Tags
none
COMPASS Pathways Plc American Depository Shares

Nasdaq:CMPS

CMPS Rankings

CMPS Stock Data

563.83M
36.86M
28.37%
39.91%
4.58%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States of America
CHESIRE

About CMPS

compass pathways is a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health. our first major initiative is developing psilocybin therapy through late-stage clinical trials in the eu and us for patients with treatment-resistant depression. we are developing psychoactive care pathways based on advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.